美国 · 股市与财经 · Quartz
Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion
Hansoh will receive $400 million upfront and keep rights to the programs in mainland China, Hong Kong, Macau and Taiwan
在 Quartz 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (qz.com)




